載入...
Predictors for eltrombopag response in patients with hepatitis C virus-associated thrombocytopenia
BACKGROUND AND AIMS: Thrombocytopenia is a common hematological abnormality observed in patients infected with hepatitis C virus (HCV). The use of eltrombopag has been approved for HCV-associated thrombocytopenia. This is the first study aiming to determine the predictive factors of response to eltr...
Na minha lista:
| 發表在: | Ther Clin Risk Manag |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6375108/ https://ncbi.nlm.nih.gov/pubmed/30804674 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S186106 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|